Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 9;10(1):32.
doi: 10.3390/genes10010032.

Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy

Wanxia Gai  1   2 , Kun Sun  3   4
Affiliations
Review

Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy

Wanxia Gai et al. Genes (Basel). .

Abstract

Cell-free circulating DNA (cfDNA) in plasma has gained global interest as a diagnostic material for noninvasive prenatal testing and cancer diagnosis, or the so-called "liquid biopsy". Recent studies have discovered a great number of valuable genetic and epigenetic biomarkers for cfDNA-based liquid biopsy. Considering that the genetic biomarkers, e.g., somatic mutations, usually vary from case to case in most cancer patients, epigenetic biomarkers that are generalizable across various samples thus possess certain advantages. In this study, we reviewed the most recent studies and advances on utilizing epigenetic biomarkers for liquid biopsies. We first reviewed more traditional methods of using tissue/cancer-specific DNA methylation biomarkers and digital PCR or sequencing technologies for cancer diagnosis, as well as tumor origin determination. In the second part, we discussed the emerging novel approaches for exploring the biological basis and clinical applications of cfDNA fragmentation patterns. We further provided our comments and points of view on the future directions on epigenetic biomarker development for cfDNA-based liquid biopsies.

Keywords: DNA methylation; cancer testing; cell-free DNA; fragmentation pattern; plasma; preferred ends; tissue-of-origin analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Mandel P., Metais P. Les acides nucléiques du plasma sanguin chez l’homme. C. R. Seances Soc. Biol. Fil. 1948;142:241–243. - PubMed
    1. Sun K., Jiang P., Chan K.C.A., Wong J., Cheng Y.K., Liang R.H., Chan W.K., Ma E.S., Chan S.L., Cheng S.H., et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc. Natl. Acad. Sci. USA. 2015;112:E5503–E5512. doi: 10.1073/pnas.1508736112. - DOI - PMC - PubMed
    1. Lui Y.Y.N., Chik K.W., Chiu R.W.K., Ho C.Y., Lam C.W., Lo Y.M.D. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin. Chem. 2002;48:421–427. - PubMed
    1. Lo Y.M.D., Tein M.S., Pang C.C., Yeung C.K., Tong K.L., Hjelm N.M. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet. 1998;351:1329–1330. doi: 10.1016/S0140-6736(05)79055-3. - DOI - PubMed
    1. Lo Y.M.D., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., Wainscoat J.S. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487. doi: 10.1016/S0140-6736(97)02174-0. - DOI - PubMed

Publication types

LinkOut - more resources